The MDR specifies that no changes may be made to the intended use or the design of medical devices to be placed on the market as MDD-certified products during the transition period. Any planned changes that had to be previously registered under the MDD must still be reported to the Notified Body.
Products that are to undergo changes to their intended use or design must first pass a conformity assessment procedure under the MDR.